The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Actinium Pharmaceuticals (Inst)
Rapid reduction of peripheral blasts in older patients with refractory acute myeloid leukemia (AML) using reinduction with single agent anti-CD45 targeted iodine (131I) apamistamab [Iomab-B] radioimmunotherapy in the phase III SIERRA trial.
 
Ben Kent Tomlinson
No Relationships to Disclose
 
Vijay Reddy
Employment - Actinium Pharmaceuticals; Pharmacyclics/Janssen
Stock and Other Ownership Interests - Actinium Pharmaceuticals
 
Mark S. Berger
Employment - Actinium Pharmaceuticals
Leadership - Actinium Pharmaceuticals
Stock and Other Ownership Interests - Actinium Pharmaceuticals
 
Jennifer Spross
Employment - Actinium Pharmaceuticals
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Actinium Pharmaceuticals (I)
Travel, Accommodations, Expenses - Actinium Pharmaceuticals
 
Renee Lichtenstein
Employment - Actinium Pharmaceuticals
Stock and Other Ownership Interests - Actinium Pharmaceuticals
Travel, Accommodations, Expenses - Actinium Pharmaceuticals
 
Boglarka Gyurkocza
No Relationships to Disclose